PEPID Pulse: Heat Stroke - Recognition, Rapid Cooling, and Critical Care & Enlicitide (Lipfendra) - The First Oral PCSK9 Inhibitor

Preview text: Don't miss out on what's new, stay updated once a month with the latest & greatest in…

Wednesday, Aug 12, 2026 at 6:01 AM EasternActiveCampaign

PEPIDPEPID Pulse: Heat Stroke - Recognition, Rapid Cooling, and Critical Care & Enlicitide (Lipfendra) - The First Oral PCSK9 Inhibitor

Image not available

No image available for this email.

Subject: PEPID Pulse: Heat Stroke - Recognition, Rapid Cooling, and Critical Care & Enlicitide (Lipfendra) - The First Oral PCSK9 Inhibitor
Preview text: Don't miss out on what's new, stay updated once a month with the latest & greatest in…
From: marketing@pepid.org
Brand: PEPID
ESP: ActiveCampaign
Sent: Wed Aug 12, 2026, 6:01 AM ET
Size: 84 KB
Images: 15
Links: 23, 5 of them buttons
Subject length: 132 characters

Against PEPID's usual

Sent in the 6 AM hour, which holds 6% of its emails; 32% arrive in the 3 AM hour. The subject is 132 characters; its average is 56.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: PEPID <[email protected]>
Subject: PEPID Pulse: Heat Stroke - Recognition, Rapid Cooling, and Critical Care & Enlicitide (Lipfendra) - The First Oral PCSK9 Inhibitor
Date: Wed, 12 Aug 2026 10:01:49 +0000 (GMT)
Message-ID domain: service-v2-7f8d4c495b-qs49m
Return-Path domain: em-777810.pepid.org
DKIM signature: d=pepid.org s=acdkim1; d=acems3.com s=acdkim1
List-Unsubscribe: Present, one-click
Mailer: ActiveCampaign Mailer
Feedback-ID sender: activecampaign

Other sending headers (names only): X-KumoRef, X-DKIM-Options, X-Virtual-Mta, X-250ok-CID, x-schedule, X-Sending-Engine, X-Report-Abuse, X-lid, X-mid

	Aug 21, 2026 4:43 AM	One shift. Multiple decisions.
	Aug 20, 2026 6:01 AM	When the question changes, your reference shouldn’t
	Aug 14, 2026 3:02 AM	Labor Day pricing is here early: EM Complete now 10% off
	Aug 12, 2026 6:01 AM	PEPID Pulse: Heat Stroke - Recognition, Rapid Cooling, and Critical Care & Enlicitide (Lipfendra) - The First Oral PCSK9 Inhibitor (this email)
	Aug 7, 2026 1:17 PM	💉 FDA Approves mFLUSIVA, First mRNA Flu Vaccine
	Jul 21, 2026 4:03 PM	⚠️ Cyclosporiasis Outbreak Update — What Providers Need to Know Now
	Jul 8, 2026 6:09 AM	PEPID Pulse: Tebipenem Pivoxil (Utebzi), First Oral Carbapenem Approved for Complicated Urinary Tract Infections & Ebola Virus Disease, From Zoonotic Exposure to Hemorrhagic Fever